Tien Liang BioTech Co., Ltd. (TPEX:4127)

Tien Liang BioTech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,757	1,899	664	707	677	513
Market Cap Growth	-5.07%	186.21%	-6.15%	4.39%	32.14%	18.77%
Enterprise Value	2,189	1,835	619	721	727	578
Last Close Price	38.40	41.50	14.30	15.23	14.59	11.04
PE Ratio	-	162.37	37.42	11.89	14.53	-
PS Ratio	3.76	4.93	1.44	1.34	1.19	1.19
PB Ratio	3.67	3.97	1.35	1.49	1.64	1.40
P/TBV Ratio	3.68	3.98	1.35	1.49	1.64	1.40
P/FCF Ratio	40.63	42.87	10.25	33.88	15.18	-
P/OCF Ratio	29.16	39.28	9.52	32.31	14.98	-
EV/Sales Ratio	4.69	4.76	1.35	1.37	1.27	1.34
EV/EBITDA Ratio	171.21	198.41	21.48	10.56	13.43	-
EV/EBIT Ratio	-	3094.22	32.79	12.37	16.93	-
EV/FCF Ratio	50.61	41.42	9.57	34.56	16.30	-
Debt / Equity Ratio	1.38	0.70	0.14	0.21	0.32	0.47
Debt / EBITDA Ratio	51.44	34.42	2.42	1.47	2.42	-
Debt / FCF Ratio	15.21	7.57	1.10	4.86	2.97	-
Net Debt / Equity Ratio	0.90	0.43	-0.14	-0.01	0.03	0.16
Net Debt / EBITDA Ratio	35.01	22.14	-2.48	-0.09	0.26	-1.57
Net Debt / FCF Ratio	9.98	4.62	-1.10	-0.31	0.32	-4.88
Asset Turnover	0.47	0.50	0.69	0.79	0.89	0.68
Inventory Turnover	3.28	2.31	2.04	2.46	4.11	3.25
Quick Ratio	0.37	0.42	1.50	1.11	0.97	0.76
Current Ratio	0.47	0.61	2.13	1.76	1.32	1.04
Return on Equity (ROE)	-0.68%	2.41%	3.66%	13.38%	11.93%	-13.13%
Return on Assets (ROA)	0.20%	0.05%	1.77%	5.47%	4.19%	-4.97%
Return on Invested Capital (ROIC)	0.38%	0.10%	4.08%	13.00%	9.61%	-11.39%
Return on Capital Employed (ROCE)	0.70%	0.10%	3.70%	11.90%	10.00%	-13.20%
Earnings Yield	-0.18%	0.62%	2.67%	8.41%	6.88%	-10.08%
FCF Yield	2.46%	2.33%	9.75%	2.95%	6.59%	-2.33%
Dividend Yield	-	-	3.50%	-	-	-
Payout Ratio	-	195.62%	-	-	-	-
Buyback Yield / Dilution	0.04%	0.04%	-0.01%	-0.05%	-	-
Total Shareholder Return	0.04%	0.04%	3.49%	-0.05%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.